Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of Levo-Carnitine for Vasopressor Dependent Septic Shock

NCT01665092 is registered in ClinicalTrials.gov with University of Mississippi Medical Center as lead sponsor.

NCT NCT01665092
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01665092 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of Levo-Carnitine for Vasopressor Dependent Septic Shock
Lead sponsor
University of Mississippi Medical Center
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2013
Completion date
March 31, 2019
Enrollment
250 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock